Enfusion, Inc.Enfusion, Inc.Enfusion, Inc.

Enfusion, Inc.

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
0.04USD
Revenue estimate
‪47.62 M‬USD
Market capitalization
‪1.19 B‬USD
‪6.33 M‬USD
‪174.54 M‬USD
‪46.60 M‬
Beta (1Y)
0.96

About Enfusion, Inc.

CEO
Oleg Movchan
Headquarters
Chicago
Employees (FY)
‪1.1 K‬
Founded
2006
FIGI
BBG012MBFQD7
Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. It is a software-as-a-service firm that develops a platform to eliminate technology and information barriers, and simplify investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset. The company was founded by Tarek Hammoud, Stephen M. Malherbe, Oleg Movchan, and Scott Werner in 2006 and is headquartered in Chicago, IL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ENFN is 9.42 USD — it has increased by 1.29% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Enfusion, Inc. stocks are traded under the ticker ENFN.
Enfusion, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
ENFN stock is 3.29% volatile and has beta coefficient of 0.96. Check out the list of the most volatile stocks — is Enfusion, Inc. there?
ENFN earnings for the last quarter are 0.02 USD per share, whereas the estimation was 0.04 USD resulting in a −52.56% surprise. The estimated earnings for the next quarter are 0.06 USD per share. See more details about Enfusion, Inc. earnings.
Enfusion, Inc. revenue for the last quarter amounts to ‪44.36 M‬ USD despite the estimated figure of ‪43.90 M‬ USD. In the next quarter revenue is expected to reach ‪45.17 M‬ USD.
Yes, you can track Enfusion, Inc. financials in yearly and quarterly reports right on TradingView.
ENFN stock has risen by 0.96% compared to the previous week, the month change is a 2.39% rise, over the last year Enfusion, Inc. has showed a 12.95% increase.
ENFN net income for the last quarter is ‪638.00 K‬ USD, while the quarter before that showed ‪1.83 M‬ USD of net income which accounts for −65.10% change. Track more Enfusion, Inc. financial stats to get the full picture.
Today Enfusion, Inc. has the market capitalization of ‪835.80 M‬, it has decreased by 0.43% over the last week.
No, ENFN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ENFN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Enfusion, Inc. stock right from TradingView charts — choose your broker and connect to your account.
ENFN reached its all-time high on Nov 15, 2021 with the price of 23.21 USD, and its all-time low was 7.37 USD and was reached on May 16, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has ‪1.10 K‬ employees. See our rating of the largest employees — is Enfusion, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Enfusion, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Enfusion, Inc. stock shows the sell signal. See more of Enfusion, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Enfusion, Inc. future price: according to them, ENFN price has a max estimate of 12.00 USD and a min estimate of 8.00 USD. Read a more detailed Enfusion, Inc. forecast: see what analysts think of Enfusion, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Enfusion, Inc. EBITDA is ‪25.77 M‬ USD, and current EBITDA margin is 11.77%. See more stats in Enfusion, Inc. financial statements.